Therapeutic Proteins and Oral Vaccines Market, By Therapeutic Protein Type (Monoclonal Antibodies, Enzymes, Growth Factors, Interferons, Interleukins and Vaccines), By Delivery Method, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
REPORT HIGHLIGHT
Therapeutic Proteins and Oral Vaccines Market size was valued at USD 251.45 Million in 2023, expanding at a CAGR of 7.9% from 2024 to 2032.
The Therapeutic Proteins and Oral Vaccines market encompasses treatments utilizing proteins and convenient oral vaccines. This growth is fueled by the rising need for these therapies, particularly in cancer, diabetes, and infectious diseases. Increased clinical trials, advancements in protein engineering, and growing government support for research are propelling the market forward. However, high manufacturing costs and stringent regulatory hurdles pose challenges. Despite these, the potential for personalized medicine using therapeutic proteins and the growing demand for needle-free vaccination present exciting market opportunities.
Therapeutic Proteins and Oral Vaccines Market- Market Dynamics
Personalized Medicine & Easy Prevention Drive Therapeutic Protein & Oral Vaccine Market Growth
Personalized medicine and easy prevention strategies using therapeutic proteins and oral vaccines are fueling a boom in the healthcare market. American Cancer Society data shows CAR-T cell therapy, a personalized protein treatment, achieving an 80% remission rate in some leukemias. Furthermore, a 2023 World Health Organization report suggests oral vaccines could raise childhood immunization rates in developing countries by 20% due to their user-friendliness. This confluence of personalized treatments and convenient preventative methods is driving substantial investment and propelling market growth within the Therapeutic Protein and Oral Vaccine sectors.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL THERAPEUTIC PROTEINS AND ORAL VACCINES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
Abbott Laboratories
Amgen Inc.
Biogen Inc.
Eli Lilly and Company
Emergent Biosolutions Inc.
F. Hoffmann-La Roche Ltd
Johnson & Johnson
Lumen Bioscience Inc.
Merck & Co., Inc.
MigVax Ltd
Neurelis Inc.
Novo Nordisk A/S
Pfizer Inc.
Sanofi S.A.
Serum Institute of India Pvt. Ltd.
TransAlgae
Others
GLOBAL THERAPEUTIC PROTEINS AND ORAL VACCINES MARKET, BY THERAPEUTIC PROTEIN TYPE- MARKET ANALYSIS, 2019 - 2032
Monoclonal Antibodies
Enzymes
Growth Factors
Interferons
Interleukins
Vaccines
GLOBAL THERAPEUTIC PROTEINS AND ORAL VACCINES MARKET, BY DELIVERY METHOD- MARKET ANALYSIS, 2019 - 2032
Injection
Inhalation
Topical application
GLOBAL THERAPEUTIC PROTEINS AND ORAL VACCINES MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032
Cancer
Autoimmune Diseases
Infectious Diseases
Neurological Disorders
Metabolic Disorders
Other Diseases
GLOBAL THERAPEUTIC PROTEINS AND ORAL VACCINES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
o The U.S.
o Canada
Europe
o Germany
o France
o Italy
o Spain
o United Kingdom
o Russia
o Netherlands
o Sweden
o Poland
o Rest of Europe
Asia Pacific
o India
o China
o South Korea
o Japan
o Australia
o Thailand
o Indonesia
o Philippines
o Rest of APAC
Latin America
o Brazil
o Mexico
o Argentina
o Colombia
o Rest of LATAM
The Middle East and Africa
o Saudi Arabia
o United Arab Emirates
o Israel
o Turkey
o Algeria
o Egypt
o Rest of MEA
TABLE OF CONTENT
1. Therapeutic Proteins and Oral Vaccines Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Therapeutic Proteins and Oral Vaccines Market Snippet by Therapeutic Protein Type
2.1.2. Therapeutic Proteins and Oral Vaccines Market Snippet by Delivery Method
2.1.3. Therapeutic Proteins and Oral Vaccines Market Snippet by Application
2.1.4. Therapeutic Proteins and Oral Vaccines Market Snippet by Country
2.1.5. Therapeutic Proteins and Oral Vaccines Market Snippet by Region
2.2. Competitive Insights
3. Therapeutic Proteins and Oral Vaccines Key Market Trends
3.1. Therapeutic Proteins and Oral Vaccines Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Therapeutic Proteins and Oral Vaccines Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Therapeutic Proteins and Oral Vaccines Market Opportunities
3.4. Therapeutic Proteins and Oral Vaccines Market Future Trends
4. Therapeutic Proteins and Oral Vaccines Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Therapeutic Proteins and Oral Vaccines Market: COVID-19 Impact Analysis
5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
5.2.1. Top Performing Segments
5.2.2. Marginal Growth Segments
5.2.3. Top Looser Segments
5.2.4. Marginal Loss Segments
6. Therapeutic Proteins and Oral Vaccines Market Landscape
6.1. Therapeutic Proteins and Oral Vaccines Market Share Analysis, 2023
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Therapeutic Proteins and Oral Vaccines Market – By Therapeutic Protein Type
7.1. Overview
7.1.1. Segment Share Analysis, By Therapeutic Protein Type, 2023 & 2032 (%)
7.1.2. Monoclonal Antibodies
7.1.3. Enzymes
7.1.4. Growth Factors
7.1.5. Interferons
7.1.6. Interleukins
7.1.7. Vaccines
8. Therapeutic Proteins and Oral Vaccines Market – By Delivery Method
8.1. Overview
8.1.1. Segment Share Analysis, By Delivery Method, 2023 & 2032 (%)
8.1.2. Injection
8.1.3. Inhalation
8.1.4. Topical application
9. Therapeutic Proteins and Oral Vaccines Market – By Application
9.1. Overview
9.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
9.1.2. Cancer
9.1.3. Autoimmune Diseases
9.1.4. Infectious Diseases
9.1.5. Neurological Disorders
9.1.6. Metabolic Disorders
9.1.7. Other Diseases
10. Therapeutic Proteins and Oral Vaccines Market– By Geography
10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
10.2. North America
10.2.1. Overview
10.2.2. Therapeutic Proteins and Oral Vaccines Key Manufacturers in North America
10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.2.4. North America Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
10.2.5. North America Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
10.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.2.7. U.S.
10.2.7.1. Overview
10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.2.7.3. U.S. Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
10.2.7.4. U.S. Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
10.2.7.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.2.8. Canada
10.2.8.1. Overview
10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.2.8.3. Canada Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
10.2.8.4. Canada Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
10.2.8.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3. Europe
10.3.1. Overview
10.3.2. Therapeutic Proteins and Oral Vaccines Key Manufacturers in Europe
10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.3.4. Europe Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
10.3.5. Europe Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
10.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.7. Germany
10.3.7.1. Overview
10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.7.3. Germany Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
10.3.7.4. Germany Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
10.3.7.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.8. Italy
10.3.8.1. Overview
10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.8.3. Italy Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
10.3.8.4. Italy Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
10.3.8.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.9. United Kingdom
10.3.9.1. Overview
10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.9.3. United Kingdom Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
10.3.9.4. United Kingdom Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
10.3.9.5. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.10. France
10.3.10.1. Overview
10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.10.3. France Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
10.3.10.4. France Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
10.3.10.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.11. Russia
10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.11.2. Russia Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
10.3.11.3. Russia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
10.3.11.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.12. Netherlands
10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.12.2. Netherlands Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
10.3.12.3. Netherlands Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
10.3.12.4. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.13. Sweden
10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.13.2. Sweden Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
10.3.13.3. Sweden Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
10.3.13.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.14. Poland
10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.14.2. Poland Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
10.3.14.3. Poland Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
10.3.14.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.15. Rest of Europe
10.3.15.1. Overview
10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.15.3. Rest of the Europe Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
10.3.15.4. Rest of the Europe Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
10.3.15.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4. Asia Pacific (APAC)
10.4.1. Overview
10.4.2. Therapeutic Proteins and Oral Vaccines Key Manufacturers in Asia Pacific
10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.4.4. Asia Pacific Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
10.4.5. Asia Pacific Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
10.4.6. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.7. India
10.4.7.1. Overview
10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.7.3. India Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
10.4.7.4. India Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
10.4.7.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.8. China
10.4.8.1. Overview
10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.8.3. China Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
10.4.8.4. China Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
10.4.8.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.9. Japan
10.4.9.1. Overview
10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.9.3. Japan Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
10.4.9.4. Japan Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
10.4.9.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.10. South Korea
10.4.10.1. Overview
10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.10.3. South Korea Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
10.4.10.4. South Korea Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
10.4.10.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.11. Australia
10.4.11.1. Overview
10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.11.3. Australia Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
10.4.11.4. Australia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
10.4.11.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.12. Thailand
10.4.12.1. Overview
10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.12.3. Thailand Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
10.4.12.4. Thailand Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
10.4.12.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.13. Indonesia
10.4.13.1. Overview
10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.13.3. Indonesia Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
10.4.13.4. Indonesia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
10.4.13.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.14. Philippines
10.4.14.1. Overview
10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.14.3. Philippines Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
10.4.14.4. Philippines Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
10.4.14.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.15. Rest of APAC
10.4.15.1. Overview
10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.15.3. Rest of APAC Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
10.4.15.4. Rest of APAC Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
10.4.15.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5. Latin America
10.5.1. Overview
10.5.2. Therapeutic Proteins and Oral Vaccines Key Manufacturers in Latin America
10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.5.4. Latin America Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
10.5.5. Latin America Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
10.5.6. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.7. Brazil
10.5.7.1. Overview
10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.7.3. Brazil Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
10.5.7.4. Brazil Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
10.5.7.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.8. Mexico
10.5.8.1. Overview
10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.8.3. Mexico Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
10.5.8.4. Mexico Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
10.5.8.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.9. Argentina
10.5.9.1. Overview
10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.9.3. Argentina Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
10.5.9.4. Argentina Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
10.5.9.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.10. Colombia
10.5.10.1. Overview
10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.10.3. Colombia Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
10.5.10.4. Colombia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
10.5.10.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.11. Rest of LATAM
10.5.11.1. Overview
10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.11.3. Rest of LATAM Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
10.5.11.4. Rest of LATAM Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
10.5.11.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6. Middle East and Africa
10.6.1. Overview
10.6.2. Therapeutic Proteins and Oral Vaccines Key Manufacturers in Middle East and Africa
10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.6.4. Middle East and Africa Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
10.6.5. Middle East and Africa Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
10.6.6. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.7. Saudi Arabia
10.6.7.1. Overview
10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.7.3. Saudi Arabia Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
10.6.7.4. Saudi Arabia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
10.6.7.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.8. United Arab Emirates
10.6.8.1. Overview
10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.8.3. United Arab Emirates Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
10.6.8.4. United Arab Emirates Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
10.6.8.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.9. Israel
10.6.9.1. Overview
10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.9.3. Israel Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
10.6.9.4. Israel Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
10.6.9.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.10. Turkey
10.6.10.1. Overview
10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.10.3. Turkey Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
10.6.10.4. Turkey Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
10.6.10.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.11. Algeria
10.6.11.1. Overview
10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.11.3. Algeria Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
10.6.11.4. Algeria Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
10.6.11.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.12. Egypt
10.6.12.1. Overview
10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.12.3. Egypt Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
10.6.12.4. Egypt Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
10.6.12.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.13. Rest of MEA
10.6.13.1. Overview
10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.13.3. Rest of MEA Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
10.6.13.4. Rest of MEA Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
10.6.13.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11. Key Vendor Analysis- Therapeutic Proteins and Oral Vaccines Industry
11.1. Competitive Dashboard
11.2. Company Profiles
11.2.1. Abbott Laboratories
11.2.2. Amgen Inc.
11.2.3. Biogen Inc.
11.2.4. Eli Lilly and Company
11.2.5. Emergent Biosolutions Inc.
11.2.6. F. Hoffmann-La Roche Ltd
11.2.7. Johnson & Johnson
11.2.8. Lumen Bioscience Inc.
11.2.9. Merck & Co., Inc.
11.2.10. MigVax Ltd
11.2.11. Neurelis Inc.
11.2.12. Novo Nordisk A/S
11.2.13. Pfizer Inc.
11.2.14. Sanofi S.A.
11.2.15. Serum Institute of India Pvt. Ltd.
11.2.16. TransAlgae
11.2.17. Others
12. 360 Degree Analyst View
13. Appendix
13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us
